AbCellera Biologics Cash Flow Statement (2020-2025) | ABCL

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -2.09M6.70M-2.69M161.16M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Depreciation and Depletion 0.41M1.10M0.81M0.84M1.10M1.20M1.30M1.40M2.30M2.50M2.79M2.90M3.00M3.10M3.90M3.20M3.40M3.80M2.10M4.41M4.50M4.30M
Share-based Compensation 1.24M0.61M1.93M4.62M5.43M8.47M7.71M9.04M12.29M12.11M11.75M13.32M15.47M16.40M15.86M16.45M17.41M17.78M17.16M15.23M14.79M14.21M13.89M
Deferred Taxes 0.62M0.13M-4.02M1.25M
Gains from Sales and Divestitures 0.04M0.06M0.19M
Gains from Investment Securities 0.03M0.22M-0.69M19.69M12.20M8.31M6.59M3.22M8.34M7.36M4.08M5.91M4.47M2.20M3.54M3.48M5.91M4.91M25.07M-16.18M1.88M2.55M2.45M
Non-cash Items 25.04M18.05M17.96M0.10M19.83M20.71M22.46M113.40M
Cash from Operations -0.76M25.98M-3.80M1.28M109.55M157.68M-5.93M-16.71M100.22M273.01M-126.79M30.91M-44.06M19.90M-0.11M-19.61M-41.71M-29.97M-28.88M-8.00M-11.55M-32.40M-52.59M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.16M0.10M0.56M1.70M2.46M2.46M2.50M2.63M2.61M2.61M2.63M11.05M2.66M2.66M2.67M3.65M1.92M32.84M33.09M10.46M1.27M1.59M1.99M
Depreciation & Amortization (CF) 0.41M1.10M0.81M0.84M1.10M1.20M1.30M1.40M2.30M2.50M2.79M2.90M3.00M3.10M3.90M3.20M3.40M3.80M2.10M4.41M4.50M4.30M
Change in Working Capital
Change in Receivables 26.61M-17.39M7.77M-11.53M30.07M-1.73M5.99M3.06M8.75M-1.79M-3.29M19.04M-7.92M32.18M11.23M10.44M18.58M15.86M19.82M20.86M1.13M11.39M3.43M
Change in Account Payables -0.16M1.67M1.38M24.25M-7.13M3.49M-22.91M21.91M22.86M5.19M-32.73M1.52M-16.25M-4.88M4.75M4.15M
Change in Accured Expenses -4.88M4.75M4.15M6.62M-3.41M-3.95M5.07M
Change in Taxes -6.12M-24.21M0.77M16.03M69.97M-17.71M-87.19M-53.67M-12.61M35.50M5.80M1.78M-3.18M-2.77M-2.76M15.36M-4.41M-3.18M-12.20M
Investing Activities
Capital Expenditures 0.58M3.70M3.88M1.50M3.64M36.80M8.57M9.43M14.49M31.32M12.51M12.33M14.98M27.20M20.33M14.43M24.14M20.11M18.52M15.63M10.64M13.37M8.93M
Change in Intangibles 5.00M
Change in Acquisitions & Divestments 18.08M57.29M88.51M272.43M92.39M262.64M160.18M220.10M268.02M306.55M232.84M196.60M201.89M190.03M113.41M83.10M
Cash from Investing Activities -5.58M-2.13M-3.88M-108.18M-15.84M-45.63M-269.63M-1.15M-26.37M-27.20M-281.99M-17.06M-149.61M-34.39M-12.79M-24.32M29.91M52.10M3.70M35.70M7.93M-31.81M36.49M
Financing Activities
Other financing activities 0.80M
Debt Issuance and Repayment
Long-Term Debt Issuances 16.17M-0.66M0.01M-0.03M6.56M2.12M2.37M3.10M
Long-Term Debt Repayments 2.03M-0.06M15.00M2.97M1.72M0.11M
Short-Term Debt repayments 0.39M
Change in Capital Stock
Shares Issued 0.12M0.13M0.64M521.95M0.17M1.71M0.90M1.83M0.49M0.33M0.26M0.89M0.46M0.23M
Preferred Shares Issued 74.66M0.02M-0.02M-0.00M
Misc.
Cash from Financing Activities 87.74M0.35M-14.37M609.94M-1.54M-5.08M0.90M1.83M-3.13M1.17M-0.02M0.35M-0.46M0.42M6.63M3.77M2.83M2.65M3.15M4.14M5.97M-3.38M7.37M
Exchange Rate Effect -0.48M-0.20M-0.22M-0.53M-0.20M-1.21M-8.55M0.36M-0.21M0.80M-1.06M1.07M-0.78M-0.04M0.37M-2.16M0.59M0.76M-0.54M
Change in Cash 81.39M24.19M-22.06M503.04M91.68M106.78M-274.88M-16.55M70.51M245.78M-417.35M14.56M-194.34M-13.27M-7.33M-39.10M-9.75M24.74M-21.67M29.68M2.94M-66.83M-9.28M
Beginning Cash Balance -81.39M-24.19M22.06M91.08M594.12M685.79M792.57M739.53M715.54M776.48M1,285.56M871.92M990.84M808.97M793.16M799.69M707.77M645.62M664.81M595.93M602.33M619.91M504.95M
Free Cash Flow -1.35M22.27M-7.69M-0.22M105.90M120.88M-14.51M-26.14M85.72M241.69M-139.30M18.58M-59.05M-7.30M-20.44M-34.04M-65.85M-50.08M-47.40M-23.63M-22.19M-45.77M-61.52M
Net Cash Flow 81.39M24.19M-22.06M503.04M92.16M106.97M-274.66M-16.03M70.72M246.99M-408.80M14.20M-194.13M-14.07M-6.26M-40.17M-8.97M24.78M-22.04M31.84M2.35M-67.59M-8.73M